TJP1 and colitis: The colitis group demonstrated a significant reduction in colon ZO‐1 gene expression and AMPK content by 81.15% (F = 65.2, p < 0.0001) and 69.89% (F = 78.34, p < 0.0001), respectively, compared to the normal control group.